TrueBlue, Inc. (TBI) Stock Price & Analysis

TrueBlue, Inc. (TBI) is trading at USD 12.33, up 1.48% today, as of November 10, 2026 at 16:39 UTC (US market open; quotes may be delayed), according to Nexqual market data.

TBI last closed at USD 12.15; today's session has ranged USD 11.94–12.5 on volume of 120,498 shares. Market capitalization is $375.87M, with a 52-week range of USD 3.18–13.59 (NYQ). Source: Nexqual, retrieved November 10, 2026 at 16:45 UTC.

What changed for TBI since Aug 31, 2025

The built-in knowledge of several widely used AI models ends around Aug 31, 2025. Everything below is newer, dated and sourced (as of Nov 10, 2026).

Also available as compact Markdown for AI agents: nexqual.com/TBI.md

Key facts (TBI)

Valuation (price ÷ last four quarters, through Sep 27, 2026) (TBI)

P/S 0.2x · EV/Sales 0.3x · P/B 1.4x · FCF yield -19.52% · Earnings yield -12.27% · Net debt $82.5M · EV $453M

Superinvestors (SEC 13F-HR, Q3 2026) (TBI)

1 of 80 tracked investors hold TBI. Each row is the investor's latest 13F; change is vs their prior-quarter share count.

InvestorFirm% of portfolioValueChange
Richard PzenaPzena Investment Management0.08%$26.2MReduced -7.9%

Analysts (TBI)

Consensus Hold (mean 2.50 on a 1–5 scale), 2 analysts; mean target USD 14.25 (low 14, high 14.5).

Total return (dividends reinvested) (TBI)

1Y (from 2025-11-10)5Y (from 2021-11-08)
Total return+153.2%-54.4%
S&P 500 (SPY)+10.9%+71.1%
Per year+153.3%-14.5%
Volatility (annualized)70.6%56.9%
Max drawdown-40.3% (Jan 2026→Mar 2026)-88.7% (Mar 2022→Mar 2026)

Dividends (TBI)

TBI paid no cash dividend in the last five years.

Short interest (TBI)

424,240 shares sold short, 1.69% of the float, as of Oct 15, 2026 (exchange short-interest report, published about twice a month). Prior report (Sep 15, 2026): 821,435 shares (-48.4%). Days to cover: 1.7 (short shares ÷ average daily volume).

TBI earnings history and stock reaction

Results filedQuarterEPSConsensusSurpriseStock reaction
—Quarter ended Sep 30, 2026$0.33$0.19Beat +73.7%—
—Quarter ended Jun 30, 2026$0.06−$0.10Beat +$0.16—
—Quarter ended Mar 31, 2026−$0.41−$0.45Beat +8.9%—
—Quarter ended Dec 31, 2025−$0.25−$0.05Miss −400.0%—

EPS as reported against the analyst consensus before the release; surprise uses the cent-rounded figures shown (in dollars when EPS and consensus have opposite signs). Stock reaction = close before the results to close after (the first close following a release after the bell or before the open).

TBI analyst estimates and revisions

PeriodEPS estimate90 days agoChangeRevenue estimateAnalysts
Current quarter (ends Dec 2026)$0.08$0.14-44.2%$469.0M3
Next quarter (ends Mar 2027)$-0.01$-0.04+$0.03$443.9M2
Current fiscal year (ends Dec 2026)$0.07$-0.02+$0.08$1.80B3
Next fiscal year (ends Dec 2027)$0.82$0.62+31.0%$1.91B3

TBI options: expected move

ExpirationDaysATM implied volatilityExpected move
Nov 20, 202610207.0%±27.6%
Feb 19, 202710156.1%±30.5%
May 21, 202719258.8%±40.2%

30-day implied volatility 74.1% vs 76.4% realized over the last 30 trading days. Put/call ratio (volume) 0.5. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.

Key Statistics (as of November 10, 2026 at 16:45 UTC)

PriceUSD 12.33
Change▲ 1.48% (up)
Previous CloseUSD 12.15
OpenUSD 11.99
Day RangeUSD 11.94 – 12.5
52-Week RangeUSD 3.18 – 13.59
Volume120,498 shares
Market Cap$375.87M
ExchangeNYQ

Technical Analysis (TBI)

Nexqual's technical model rates TBI "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of November 10, 2026 at 16:45 UTC.

Overall SignalBUY
RSI (14)77.05 (overbought)
vs SMA50Above (USD 9.5)
MACD0.74 (positive)

Analyst Ratings (TBI)

Wall Street analysts rate TBI "Hold" based on 2 analysts, with a mean price target of USD 14.25 (range USD 14–14.5), per Nexqual as of November 10, 2026 at 16:45 UTC.

Consensus RatingHold
Analyst Count2
Mean TargetUSD 14.25
High TargetUSD 14.5
Low TargetUSD 14
Buy / Hold / Sell1 / 1 / 0

Earnings (TBI)

Next Earnings Date2026-11-04
EPS EstimateUSD 0.08
Revenue Estimate$469.00M

Recent Earnings History

QuarterActual vs Estimate
2026-09-30USD 0.33 vs est 0.19 ▲ beat
2026-06-30USD 0.06 vs est -0.1 ▲ beat
2026-03-31USD -0.41 vs est -0.45 ▲ beat
2025-12-31USD -0.25 vs est -0.05 ▼ miss

Source: Nexqual, November 10, 2026 at 16:45 UTC.

Financials & Fundamentals (TBI)

Total Revenue$1.78B
Revenue Growth (latest quarter, YoY)+20.70%
Gross Margin+20.95%
Operating Margin+2.30%
Profit Margin-2.55%
ROE-15.92%
Debt / Equity0.59
Current Ratio2.33
Total Cash$19.77M
Total Debt$156.05M
Free Cash Flow (last four quarters to Sep 2026, SEC 10-Q / 10-K)-$72.31M (-4.1% of revenue)

Source: Nexqual, November 10, 2026 at 16:45 UTC.

Financial Health Score (TBI)

Nexqual rates TrueBlue, Inc.'s overall financial health "Weak" across five dimensions, as of November 10, 2026 at 16:45 UTC.

GrowthSolid — Revenue +12% (last 4 quarters to Sep 2026 vs the 4 before, SEC)
ProfitabilityWeak — Gross margin 21%, operating -2% (last 4 quarters to Sep 2026, SEC)
Balance SheetStrong — $20M cash and investments vs $102M debt (Sep 2026, SEC)
Cash FlowWeak — FCF negative: -$72M (last 4 quarters to Sep 2026, SEC), burning cash
EfficiencyCritical — ROE -17%, ROA -6.8% (last 4 quarters, SEC)

Ownership (TBI)

Insider Ownership+7.73%
Institutional Ownership+88.98%
Shares Outstanding30.48M
Float27.85M
Short % of Float+1.69%

Source: Nexqual, November 10, 2026 at 16:45 UTC.

Leadership (TBI)

TrueBlue, Inc. is led by Taryn R. Owen, CEO, President & Director, per Nexqual as of November 10, 2026 at 16:45 UTC.

CEO, President & DirectorTaryn R. Owen
EVP & CFOCarl R. Schweihs
Executive VP & President of PeopleScoutRichard P. Betori
Senior VP and Chief Marketing & Communications OfficerCaroline Sabetti
SVP of Onsite Staffing & President of People ManagementJerry Wimer

Major Backers & Investors (TBI)

Notable institutional backers of TrueBlue, Inc. include Royce & Associates LP, Pzena Investment Management LLC, Boston Partners, according to Nexqual as of November 10, 2026 at 16:45 UTC.

Active Investors

InvestorStake
Royce & Associates LP9.43%
Pzena Investment Management LLC9.34%
Boston Partners8.13%
Ies Holdings, Inc.4.22%
Hotchkis & Wiley Capital Management, LLC3.94%
Charles Schwab Investment Management, Inc.3.92%
ROYCE FUND-Royce Small-Cap Opportunity Fund3.66%
Charles Schwab2.47%

Index Funds (Passive)

FundStake
BlackRock7.32%
Vanguard Group4.12%

Source: Nexqual, November 10, 2026 at 16:45 UTC.

From TrueBlue, Inc.'s Latest SEC 10-K Filing (filed 2026-02-18)

Key Strengths & Strategy (as disclosed to the SEC)

Legal & Regulatory Risks (Item 1A, quoted)

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
KFRCKforce, Inc.USD 54.97▲ 1.28%
KFYKorn FerryUSD 75.48▲ 0.51%
BBSIBarrett Business Services, Inc.USD 31.09▲ 2.57%
KELYBKelly Services, Inc.USD 25.88▲ 1.29%
NSPInsperity, Inc.USD 50.06▲ 1.32%
MANManpowerGroupUSD 45.23▲ 1.48%

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: November 10, 2026 at 16:45 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt